Prognia
Drug Database
🇪🇺EU · EMAOpinionATC: N05AX14

Iloperidone Vanda Pharmaceuticals(iloperidone)

Schizophrenia;Bipolar Disorder

Marketing Authorisation Holder: Vanda Pharmaceuticals Netherlands B.V.

INN: iloperidone

Indication

Treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar I disorder.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Iloperidone Vanda Pharmaceuticals — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.